Linking vaccine adjuvant mechanisms of action to function DOI
Elana Ben‐Akiva, Asheley P. Chapman, Tianyang Mao

et al.

Science Immunology, Journal Year: 2025, Volume and Issue: 10(104)

Published: Feb. 14, 2025

Vaccines deliver an immunogen in a manner designed to safely provoke immune response, leading the generation of memory T and B cells long-lived antibody-producing plasma cells. Adjuvants play critical role vaccines by controlling how system is exposed providing inflammatory cues that enable productive priming. However, mechanisms action underlying adjuvant function at molecular, cell, tissue levels are diverse often poorly understood. Here, we review current understanding adjuvants used subunit protein/polysaccharide mRNA vaccines, discuss where possible these link downstream effects on identify knowledge gaps will be important fill order continued development more effective for challenging pathogens such as HIV emerging threats.

Language: Английский

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection DOI Open Access
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino

et al.

Nature reviews. Immunology, Journal Year: 2022, Volume and Issue: 23(6), P. 381 - 396

Published: Dec. 19, 2022

Language: Английский

Citations

128

Long-primed germinal centres with enduring affinity maturation and clonal migration DOI Open Access
Jeong Hyun Lee, Henry J. Sutton, Christopher A. Cottrell

et al.

Nature, Journal Year: 2022, Volume and Issue: 609(7929), P. 998 - 1004

Published: Sept. 21, 2022

Language: Английский

Citations

125

Antibody-mediated neutralization of SARS-CoV-2 DOI Creative Commons

Henning Gruell,

Kanika Vanshylla, Timm Weber

et al.

Immunity, Journal Year: 2022, Volume and Issue: 55(6), P. 925 - 944

Published: May 13, 2022

Language: Английский

Citations

120

SARS-CoV-2 Omicron boosting induces de novo B cell response in humans DOI Open Access
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou

et al.

Nature, Journal Year: 2023, Volume and Issue: 617(7961), P. 592 - 598

Published: April 3, 2023

Language: Английский

Citations

114

Memory B cells DOI
Takeshi Inoue, Tomohiro Kurosaki

Nature reviews. Immunology, Journal Year: 2023, Volume and Issue: 24(1), P. 5 - 17

Published: July 3, 2023

Language: Английский

Citations

112

Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system DOI Creative Commons
Martyna Strzelec, Jan Detka,

Patrycja Mieszczak

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: March 9, 2023

In recent years, there has been a tremendous development of biotechnological, pharmacological, and medical techniques which can be implemented in the functional modulation immune system components. Immunomodulation attracted much attention because it offers direct applications both basic research clinical therapy. Modulation non-adequate, amplified response enables to attenuate course disease restore homeostasis. The potential targets modulate immunity are as multiple components system, thus creating various possibilities for intervention. However, immunomodulation faces new challenges design safer more efficacious therapeutic compounds. This review cross-sectional picture currently used newest pharmacological interventions, genomic editing, tools regenerative medicine involving immunomodulation. We reviewed available experimental evidence prove efficiency, safety, feasibility vitro vivo. also advantages limitations described techniques. Despite its limitations, is considered therapy itself or an adjunct with promising results developing potential.

Language: Английский

Citations

79

Durability of immune responses to mRNA booster vaccination against COVID-19 DOI Creative Commons
Prabhu S. Arunachalam, Lilin Lai, Hady Samaha

et al.

Journal of Clinical Investigation, Journal Year: 2023, Volume and Issue: 133(10)

Published: March 23, 2023

BackgroundMaintaining durable immunity following vaccination represents a major challenge, but whether mRNA booster improves durability is unknown.MethodsWe measured antibody responses in 55 healthy adults, who received dose of the Pfizer-BioNTech or Moderna vaccine against SARS-CoV-2 and calculated half-life titers. We also memory B T cell subset 28 participants. In 13 volunteers second vaccine, we serum titers responses.ResultsThe (third immunization) at 6 to 10 months increased serum-neutralizing (nAb) 76 days from 56 66 after primary 2-dose vaccination. A (fourth year further 88 days. However, despite this modestly improved nAb ancestral (WA.1) strain, there was loss neutralization capacity Omicron subvariants BA.2.75.2, BQ.1.1, XBB.1.5 (48-, 71-, 66-fold drop titers, respectively, relative WA.1 strain). Although only 45% 65% participants demonstrated detectable titer newer variants dose), response declined below detection limit almost all individuals by months. contrast, induced antigen-specific cells that persisted for least months.ConclusionThe marginally immunizations with vaccines.

Language: Английский

Citations

58

Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans DOI Creative Commons
M. Alejandra Tortorici, Amin Addetia,

Albert J. Seo

et al.

Immunity, Journal Year: 2024, Volume and Issue: 57(4), P. 904 - 911.e4

Published: March 14, 2024

Immune imprinting describes how the first exposure to a virus shapes immunological outcomes of subsequent exposures antigenically related strains. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron breakthrough infections and bivalent COVID-19 vaccination primarily recall cross-reactive memory B cells induced by prior Wuhan-Hu-1 spike mRNA rather than priming Omicron-specific naive cells. These findings indicate that immune occurs after repeated exposures, but whether it can be overcome remains unclear. To understand persistence imprinting, we investigated plasma antibody responses administration updated XBB.1.5 vaccine booster. We showed booster elicited neutralizing against current variants were dominated pre-existing previously spike. Therefore, persists multiple spikes through infection, including post vaccination, which will need considered guide future vaccination.

Language: Английский

Citations

57

Human circulating and tissue-resident memory CD8+ T cells DOI
Marcus Buggert, David A. Price, Laura K. Mackay

et al.

Nature Immunology, Journal Year: 2023, Volume and Issue: 24(7), P. 1076 - 1086

Published: June 22, 2023

Language: Английский

Citations

48

Immune imprinting and next-generation coronavirus vaccines DOI
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell

et al.

Nature Microbiology, Journal Year: 2023, Volume and Issue: 8(11), P. 1971 - 1985

Published: Nov. 6, 2023

Language: Английский

Citations

44